Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP 53 alterations

How and when I do allogeneic transplant in CLL

(2018) John G. Gribben   BLOOD

Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party

(2018) Stephen P. Robinson et al.   BONE MARROW TRANSPLANTATION

Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial

(2018) Mats Jerkeman et al.   Lancet Haematology

Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression

(2018) Ikuno Uehara et al.   Cancers

Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network

(2016) Eva Hoster et al.   JOURNAL OF CLINICAL ONCOLOGY

Lifting the mantle: Unveiling new treatment approaches in relapsed or refractory mantle cell lymphoma

(2015) Alberto Mussetti et al.   BLOOD REVIEWS

Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era

(2015) A Mussetti et al.   BONE MARROW TRANSPLANTATION

How Do Cytotoxic Lymphocytes Kill Cancer Cells?

(2015) L. Martinez-Lostao et al.   CLINICAL CANCER RESEARCH

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

(2015) Donavan T. Cheng et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study

(2014) Lena Nordström et al.   BRITISH JOURNAL OF HAEMATOLOGY

A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies

(2014) Craig S. Sauter et al.   LEUKEMIA & LYMPHOMA

A Phase II Study of a Nonmyeloablative Allogeneic Stem Cell Transplant with Peritransplant Rituximab in Patients with B Cell Lymphoid Malignancies: Favorably Durable Event-Free Survival in Chemosensitive Patients

(2013) Craig S. Sauter et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Molecular pathogenesis of mantle cell lymphoma

(2012) Pedro Jares et al.   JOURNAL OF CLINICAL INVESTIGATION

Impact of TP53 mutation and 17p deletion in mantle cell lymphoma

(2011) A M Halldórsdóttir et al.   LEUKEMIA